RhumbLine Advisers’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Buy |
177,623
+60,059
| +51% | +$126K | ﹤0.01% | 2864 |
|
|
2025
Q1 | $200K | Buy |
117,564
+3,109
| +3% | +$5.3K | ﹤0.01% | 3101 |
|
|
2024
Q4 | $578K | Buy |
114,455
+5,005
| +5% | +$25.3K | ﹤0.01% | 2582 |
|
|
2024
Q3 | $595K | Sell |
109,450
-1,469
| -1% | -$7.99K | ﹤0.01% | 2585 |
|
|
2024
Q2 | $532K | Buy |
110,919
+51,858
| +88% | +$249K | ﹤0.01% | 2636 |
|
|
2024
Q1 | $184K | Buy |
59,061
+2,186
| +4% | +$6.8K | ﹤0.01% | 3223 |
|
|
2023
Q4 | $162K | Buy |
56,875
+1,930
| +4% | +$5.48K | ﹤0.01% | 3282 |
|
|
2023
Q3 | $161K | Buy |
54,945
+1,433
| +3% | +$4.2K | ﹤0.01% | 3270 |
|
|
2023
Q2 | $153K | Buy |
53,512
+4,400
| +9% | +$12.6K | ﹤0.01% | 3373 |
|
|
2023
Q1 | $152K | Sell |
49,112
-2,194
| -4% | -$6.79K | ﹤0.01% | 2800 |
|
|
2022
Q4 | $108K | Buy |
51,306
+28,522
| +125% | +$60K | ﹤0.01% | 2895 |
|
|
2022
Q3 | $74K | Buy |
22,784
+1,354
| +6% | +$4.4K | ﹤0.01% | 3028 |
|
|
2022
Q2 | $69K | Buy |
+21,430
| New | +$69K | ﹤0.01% | 3048 |
|